All Drugs
932 drug validation reports
This list is based on the registration data of Health Canada (Canada).
Shortlist: Canadian medicines with clinical-trial evidence for a new indication (L1–L2, with the predicted indication and the number of registered trials cited).
Evidence level breakdown
| Evidence level | Drugs | Description |
|---|---|---|
| L1 | 12 | Multiple RCTs / systematic reviews |
| L2 | 41 | Single RCT / Phase 2 trials |
| L3 | 36 | Observational studies / large case series |
| L4 | 62 | Preclinical / mechanistic studies |
| L5 | 729 | Model prediction only |
Full drug list
Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)